Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8124731 Optimized Fc variants and methods for their generation

Patent 8124731 was granted and assigned to Xencor on February, 2012 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Xencor

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

8124731

Patent Inventor Names

Gregory Alan Lazar0

Arthur J. Chirino0

John R. Desjarlais0

Omid Vafa0

Robert J. Hayes0

Sher Bahadur Karki0

Stephen K. Doberstein0

Wei Dang0

Date of Patent

February 28, 2012

Patent Application Number

11927444

Date Filed

October 29, 2007

Patent Citations Received

‌

US Patent 11773179 Antibody molecules to C5aR1 and uses thereof

‌

US Patent 11912781 Humanized complement 5A receptor 1 antibodies and methods of use thereof

‌

US Patent 11858980 Engineered polypeptides and uses thereof

Patent Primary Examiner

‌

Chun Dahle

Patent abstract

The present invention relates to optimized Fc variants, methods for their generation, and antibodies and Fc fusions comprising optimized Fc variants.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8124731 Optimized Fc variants and methods for their generation

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API